News
The most recent news and industry headlines are presented in this section. Our dedicated team closely observes the pharmaceutical industry and keeps you informed of the most recent developments around the Europe.
PhenomeX Launches Beacon Select™ Optofluidic System with Opto® B Discovery Workflows
Tuesday, May 16, 2023PhenomeX Inc Nasdaq CELL the functional cell biology company today announced the launch of Beacon Select optofluidic system with Opto B Discovery workflows for antibody discovery
ImmPACT Bio Granted FDA Fast Track Designation for IMPT-314 in Patients with Relapsed or Refractory Aggressive B-cell Lymphoma
Tuesday, May 16, 2023ImmPACT Bio USA Inc ImmPACT Bio a clinicalstage company developing transformative logicgatebased chimeric antigen receptor CAR Tcell therapies for treating cancer and autoimmune diseases today announced the US Food and Drug Administration FDA has gra...
Innovent Receives NMPA Breakthrough Designation for IBI351 (KRASG12C Inhibitor) as Monotherapy for Previously Treated Advanced Colorectal Carcinoma
Monday, May 15, 2023Innovent Biologics Inc Innovent HKEX a worldclass biopharmaceutical company that develops manufactures and commercializes highquality medicines for the treatment of oncology metabolic autoimmune ophthalmology and other major diseases announced that...
Oxford Biomedica launches the TetraVecta™ System
Monday, May 15, 2023Oxford UK May Oxford Biomedica plc LSEOXB Oxford Biomedica or the Company a quality and innovationled viral vector CDMO today announces the launch of its th generation lentiviral vector delivery system TetraVectaTM This stateoftheart technology de...
FDA approves first drug to treat symptoms of agitation associated with dementia due to Alzheimer's disease
Friday, May 12, 2023Today the US Food and Drug Administration FDA granted supplemental approval for Rexulti oral tablets brexpiprazole for the treatment of agitation associated with dementia due to Alzheimers disease This is the first FDAapproved treatment option for...
Invivoscribe Announces IVDR Approval of the LeukoStrat® CDx FLT3 Mutation Assay
Friday, May 12, 2023Today we are pleased to announce that Invivoscribes LeukoStrat CDx FLT Mutation Assay has been approved by BSI Netherlands and the EMA as a Class C CDx assay meeting the stringent new IVDR Regulation EU requirements Invivoscribe is one of the first...
Servier receives European Commission approval of Tibsovo® (ivosidenib tablets) in IDH1-mutated Acute Myeloid Leukemia and IDH1-mutated Cholangiocarcinoma
Thursday, May 11, 2023Servier a global pharmaceutical group today announced that the European Commission EC has approved Tibsovo ivosidenib tablets as a targeted therapy in two indications in combination with azacitidine for the treatment of adult patients with newly diag...
Chiesi Global Rare Diseases and Protalix BioTherapeutics Announce FDA Approval of ELFABRIO® (pegunigalsidase alfa-iwxj) for the Treatment of Fabry Disease
Thursday, May 11, 2023Chiesi Global Rare Diseases a business unit of the Chiesi Group established to deliver innovative therapies and solutions for people affected by rare diseases and Protalix BioTherapeutics Inc NYSE AmericanPLX a biopharmaceutical company focused on th...
Otsuka and Lundbeck Announce U.S. Food and Drug Administration (FDA) Approval of supplemental New Drug Application
Thursday, May 11, 2023Otsuka Pharmaceutical Co Ltd Otsuka and H Lundbeck AS Lundbeck announce the US Food and Drug Administration FDA has approved the supplemental New Drug Application sNDA of REXULTI brexpiprazole for use in the treatment of agitation associated with dem...
Amgen And Tscan Therapeutics Announce Collaboration To Identify Novel Targets In Crohns Disease
Thursday, May 11, 2023Amgen NASDAQAMGN and TScan Therapeutics Inc NASDAQTCRX today announced a multiyear collaboration that will use TScans proprietary target discovery platform TargetScan to identify the antigens recognized by T cells in patients with Crohns disease Unde...
